Balance Sheet
Accounts PayablesAccumulated ExpensesCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Dividends payables: 2023

  • Zhengye Biotechnology Holding's Dividends payables was N/A to $2.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was $2.2 million, marking a year-over-year change of. This contributed to the annual value of $2.2 million for FY2023, which is N/A change from last year.
  • According to the latest figures from Q4 2023, Zhengye Biotechnology Holding's Dividends payables is $2.2 million.
  • Over the past 5 years, Zhengye Biotechnology Holding's Dividends payables peaked at $2.2 million during Q4 2023, and registered a low of $2.2 million during Q4 2023.
  • Its 1-year average for Dividends payables is $2.2 million, with a median of $2.2 million in 2023.